We are live on ! Find out more
GNFT

Genfit

Delisted

GNFT was delisted on the 19th of November, 2025.

1 hedge funds and large institutions have $30 invested in Genfit in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.09% less ownership

Funds ownership: 0.09%0% (-0.09%)

83% less funds holding

Funds holding: 61 (-5)

100% less capital invested

Capital invested by funds: $169K → $30 (-$169K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
1
Holders Change
-5
Holders Change %
-83.33%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$30
Morgan Stanley
2
Morgan Stanley
New York
-$76.5K -20,120 Closed
SF
3
Summit Financial
New Jersey
-$71.3K -18,750 Closed
UBS Group
4
UBS Group
Switzerland
-$20.7K -5,449 Closed
Osaic Holdings
5
Osaic Holdings
Arizona
-$855 -225 Closed
PS
6
Principal Securities
Iowa
-$91 -24 Closed

GNFT Hedge Fund Activity: Q4 2025 in Review

1 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Genfit (GNFT) for Q4 2025, worth a combined $30 — down 100% from $169K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of GNFT and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, exiting entirely with an estimated $76.5K sold.

  • 1 institutional investor held Genfit (GNFT) as of Q4 2025, down from 6 in Q3 2025.
  • Funds reported $30 of Genfit stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Genfit positions in Q4 2025 and 5 closed out, a net change of -5 holders.
  • The largest Genfit seller in Q4 2025 was Morgan Stanley, an estimated $76.5K sold.

Based on aggregated 13F filings for Q4 2025.